Paragon's Harmony Biosciences brings in $330M of debt capital and equity, looking to expand narcolepsy drug label

Jeff Aronin’s Harmony Biosciences is ringing in a new financing agreement, one that’s bringing in hundreds of millions of dollars.

The Plymouth Meeting, PA-based biotech …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Paragon's Har­mo­ny Bio­sciences brings in $330M of debt cap­i­tal and eq­ui­ty, look­ing to ex­pand nar­colep­sy drug la­bel